Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells

Published:2018-11-28 Issue:12 Volume:119 Page:1495-1507
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Tian Jun,Raffa Fatmah Al,Dai Meiou,Moamer Alaa,Khadang Baharak,Hachim Ibrahim Y.,Bakdounes Khldoun,Ali Suhad,Jean-Claude Bertrand,Lebrun Jean-Jacques

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0287-3.pdf

Reference54 articles.

1. Schneider, B. P. et al. Triple-negative breast cancer: risk factors to potential targets. Clin. Cancer Res. 14, 8010–8018 (2008).

2. Andre, F. & Zielinski, C. C. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents. Ann. Oncol. 23, vi46–51 (2012).

3. Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283–296 (2012).

4. Wicha, M. S., Liu, S. & Dontu, G. Cancer stem cells: an old idea—a paradigm shift. Cancer Res. 66, 1883–1890 (2006).

5. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Changes in Breast Cancer Induced by Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. A Pyroptosis‐Inducing Arsenic(III) Nanomicelle Platform for Synergistic Cancer Immunotherapy;Advanced Healthcare Materials;2024-08-05

3. Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action;International Journal of Molecular Sciences;2024-06-06

4. Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors;Nanomedicine: Nanotechnology, Biology and Medicine;2024-06

5. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells;Biomedicine & Pharmacotherapy;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3